Article
An AI-Powered tissue-agnostic cellular morphometrics biomarker for risk assessment in patients with pan-gastrointestinal precancerous lesions and cancers
2024-11-15
Abstract excerpt
<h4>PURPOSE</h4> Tissue-agnostic biomarkers that capture the commonality in cancer biology, may provide a new avenue for treatment development and optimization across cancer types. Here, we aimed to evaluate and validate the clinical value of a tissue-agnostic cellular morphometrics biomarker (CMB) signature, which was discovered by artificial intelligence (AI) from H&E-stained whole-slide images (WSI) of diagnost...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c9f5022f-91c5-5dcf-9c12-7abbe2e55a08
- DOI
- 10.1101/2024.11.14.24317353
